Peer Review reports
From: The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer
| Original Submission | ||
|---|---|---|
| 19 Dec 2020 | Submitted | Original manuscript |
| 8 Apr 2021 | Reviewed | Reviewer Report |
| 1 May 2021 | Reviewed | Reviewer Report - Maurizio Chiriva-internati |
| 8 Jun 2021 | Author responded | Author comments - Lihua Wang |
| Resubmission - Version 2 | ||
| 8 Jun 2021 | Submitted | Manuscript version 2 |
| 10 Jun 2021 | Author responded | Author comments - Lihua Wang |
| Resubmission - Version 3 | ||
| 10 Jun 2021 | Submitted | Manuscript version 3 |
| 20 Jun 2021 | Author responded | Author comments - Lihua Wang |
| Resubmission - Version 4 | ||
| 20 Jun 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 28 Aug 2021 | Editorially accepted | |
| 3 Sep 2021 | Article published | 10.1186/s12865-021-00451-7 |
You can find further information about peer review here.